We've found
6,916 Ovarian Cancer
clinical trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials
Oncology Clinical Trial
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
Status: Enrolling
Updated: 1/18/2018
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Oncology Clinical Trial
VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status: Enrolling
Updated: 6/15/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Status: Enrolling
Updated: 12/3/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Status: Enrolling,
Phase
I
Updated: 3/11/2014
Click here to add this to my saved trials
Oncology, Ophthalmology, Other Clinical Trial
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Status: Enrolling
Updated: 9/27/2017
Click here to add this to my saved trials
Polycystic Ovary Syndrome Clinical Trial
Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 9/9/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
DOD Long-Term Survivors of Ovarian Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancers Clinical Trial
Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
6,916 Ovarian Cancer
clinical trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/16/2012
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/16/2012
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Updated: 1/18/2018
Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
Status: Enrolling
Updated: 1/18/2018
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/15/2012
VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status: Enrolling
Updated: 6/15/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/3/2012
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Status: Enrolling
Updated: 12/3/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/4/2013
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/11/2014
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Status: Enrolling,
Phase
I
Updated: 3/11/2014
Click here to add this to my saved trials
Oncology, Ophthalmology, Other Clinical Trial
Updated: 12/31/1969
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 9/27/2017
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Status: Enrolling
Updated: 9/27/2017
Click here to add this to my saved trials
Polycystic Ovary Syndrome Clinical Trial
Updated: 2/24/2016
Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 9/9/2013
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 9/9/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 1/30/2015
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 1/30/2015
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 3/15/2016
DOD Long-Term Survivors of Ovarian Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancers Clinical Trial
Updated: 12/31/1969
Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials